206 results on '"Widmark, Anders"'
Search Results
2. The grade of individual prostate cancer lesions predicted by magnetic resonance imaging and positron emission tomography
3. Hyaluronic acid spacer in prostate cancer radiotherapy: dosimetric effects, spacer stability and long-term toxicity and PRO in a phase II study
4. Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
5. Establishing paediatric diagnostic reference levels using reference curves – A feasibility study including conventional and CT examinations
6. Registration of histopathology to magnetic resonance imaging of prostate cancer
7. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
8. Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer
9. Second Cancers in Patients With Locally Advanced Prostate Cancer Randomized to Lifelong Endocrine Treatment With or Without Radical Radiation Therapy: Long-Term Follow-up of the Scandinavian Prostate Cancer Group-7 Trial
10. A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
11. Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
12. Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial
13. Radiation dosimetry of [68Ga]PSMA-11 in low-risk prostate cancer patients
14. Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [68Ga]PSMA-11-PET and [11C]Acetate-PET.
15. Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
16. Radiation Therapy Did Not Induce Long-Term Changes in Rectal Mucosa: Results From the Randomized Scandinavian Prostate Cancer Group 7 Trial
17. Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone
18. Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial
19. Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients
20. Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328.
21. Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
22. Does one have a sexual life 15 years after external beam radiotherapy for prostate cancer? Prospective patient-reported outcome of sexual function comparison with age-matched controls
23. Residual Prostate Cancer in Patients Treated With Endocrine Therapy With or Without Radical Radiotherapy: A Side Study of the SPCG-7 Randomized Trial
24. Secondary Malignancies From Prostate Cancer Radiation Treatment: A Risk Analysis of the Influence of Target Margins and Fractionation Patterns
25. Population-based study of long-term functional outcomes after prostate cancer treatment
26. Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy.
27. Inhibition of the Insulin-Like Growth Factor-1 Receptor Enhances Effects of Simvastatin on Prostate Cancer Cells in Co-Culture with Bone
28. Validation of the Intestinal Part of the Prostate Cancer Questionnaire “QUFW94”: Psychometric Properties, Responsiveness, and Content Validity
29. PD6-10 ADVERSE EVENTS AFTER RADICAL PROSTATECTOMY AND CURATIVE RADIOTHERAPY. POPULATION-BASED NATION-WIDE REGISTER STUDY
30. Quality of life in patients with locally advanced prostate cancer given endocrine treatment with or without radiotherapy: 4-year follow-up of SPCG-7/SFUO-3, an open-label, randomised, phase III trial
31. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
32. Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases
33. Establishment and validation of an in vitro co-culture model to study the interactions between bone and prostate cancer cells
34. Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0
35. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20–100 ng/mL
36. Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): a dosimetric evaluation
37. Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects
38. Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.
39. Paediatric diagnostic reference levels for common radiological examinations using the European guidelines.
40. After radiotherapy testosterone stimulation is unable to increase growth in the Dunning R3327-PAP prostate tumour
41. Do Perceptions of Adverse Events Differ Between Patients and Physicians? Findings From a Randomized, Controlled Trial of Radical Treatment for Prostate Cancer
42. Distribution of estramustine in the BT4C rat glioma model
43. Living after radical prostatectomy for localized prostate cancer. A qualitative analysis of patient narratives
44. A Systematic Overview of Radiation Therapy Effects in Prostate Cancer
45. New Principles in the Treatment of Prostate Cancer: The Oncologistʼs View
46. A Systematic Overview of Radiation Therapy Effects in Urinary Bladder Cancer
47. Daily-diary Evaluated Side Effects of Dose-escalation Radiotherapy of Prostate Cancer Using the Stereotactic Beamcath® Technique
48. Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo.
49. Tumor Blood Flow and the Cytotoxic Effects of Estramustine and Its Constituents in a Rat Glioma Model
50. Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998–2016.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.